Author:
Chen Jiang-Fan,Eltzschig Holger K.,Fredholm Bertil B.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference297 articles.
1. Fredholm, B. B. et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527–552 (2001). This is an overview of the current knowledge of adenosine receptor biology, from gene structure to expression, distribution, biochemical properties, pharmacological profiles, signalling and behavioural responses, focusing on receptor nomenclature and classification.
2. Fredholm, B. B. et al. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors — an update. Pharmacol. Rev. 63, 1–34 (2011). This is an update of reference 1, based on 10 more years of research.
3. Eltzschig, H. K., Sitkovsky, M. V. & Robson, S. C. Purinergic signaling during inflammation. N. Engl. J. Med. 367, 2322–2333 (2012). This is a comprehensive review summarizing the biomedical implications of extracellular ATP, ADP and adenosine signalling in the context of a broad range of inflammatory diseases.
4. Eltzschig, H. K. Adenosine: an old drug newly discovered. Anesthesiology 111, 904–915 (2009).
5. Johansson, S. M., Yang, J. N., Lindgren, E. & Fredholm, B. B. Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid. Acta Physiol. 190, 87–96 (2007).
Cited by
750 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献